HUB Organoids extends partnership with Molecular Devices to advance automated intestinal organoid screening technology
HUB Organoids official news RSS · Indexed industry source record · Source published: Sat Mar 04 2023 13:34:09 GMT+0000 (Coordinated Universal Time) · Indexed here: Thu Oct 08 2026 07:03:32 GMT+0000 (Coordinated Universal Time)
Saved source excerpt
SAN JOSE, Calif., and UTRECHT, Netherlands, Feb. 13, 2023 – Molecular Devices, LLC., a leading provider of high-performance life science solutions, and HUB Organoids (HUB), the pioneer in the field of adult stem cell-derived organoids, today announced a strategic collaboration enabling continued development of next-generation 3D biology technologies that drive step-change reduction in pre-clinical
This is a cited excerpt from the source. Read the original link for the complete text. Automated indexing and topic classification do not constitute fact verification.